Abdominal Aortic Aneurysm Treatment Market by Treatment (Surgery, Open Surgery, Endovascular Aneurysm, Medication, Antihypertensive, Antilipidemics), End-user (Hospitals, Clinics), & Region for 2024– 2031

Abdominal Aortic Aneurysm Treatment Market Valuation – 2024-2031

The increasing frequency of cardiovascular disorders, combined with developments in minimally invasive surgical procedures, is driving the abdominal aortic aneurysm treatment market. According to the analyst from Market Research, the abdominal aortic aneurysm treatment market is estimated to reach a valuation of USD 3.23 Billion over the forecast subjugating around USD 2.08 Billion valued in 2024.

The growing aging population and increased knowledge of early detection and treatment options are driving the abdominal aortic aneurysm treatment market. It enables the market to grow at a CAGR of 6.27% from 2024 to 2031.

Abdominal Aortic Aneurysm Treatment MarketDefinition/Overview

Abdominal aortic aneurysm (AAA) treatment involves medical procedures and interventions designed to avoid the rupture of an enlarged area in the lower part of the aorta, the body’s main blood conduit. The chief therapies are open surgical repair, which replaces the damaged part of the aorta with a synthetic graft, and endovascular aneurysm repair (EVAR), which is a less invasive surgery that uses a stent graft to rebuild the fragile artery wall.

Furthermore, these treatments are critical for preventing life-threatening consequences and are often used in individuals diagnosed with severe aneurysm enlargement using imaging techniques such as ultrasonography or CT scans.

What are the Drivers Influencing the Growth of the Abdominal Aortic Aneurysm Treatment?

The global aging population is a major driver of the Abdominal Aortic Aneurysm (AAA) Treatment Market. AAA is more common in older persons because the aorta’s walls deteriorate with time. This demographic shift is increasing the prevalence of AAA patients, generating the need for effective treatment alternatives such as operations and endovascular aneurysm repairs.

Technological advancements, including the introduction of better graft materials and minimally invasive surgical techniques, have greatly enhanced the safety and efficacy of AAA treatments. These innovations promote earlier and more frequent interventions, hence growing the therapy market. Enhanced imaging technologies also aid in the diagnosis and monitoring of aneurysms, which drives market expansion.

Furthermore, increasing worldwide healthcare spending provides for more complex AAA treatment choices. This financial infusion is being driven in part by governments and health organizations prioritizing vascular health, which has resulted in enhanced healthcare infrastructure and the availability of specialist care. Also, increasing health insurance coverage has made treatments more available to a larger population.

What are the Main Challenges Faced by the Abdominal Aortic Aneurysm Treatment Market?

AAA treatments, particularly endovascular operations, tend to be costly due to their complexity and technology. This is a severe hurdle in areas with little healthcare financing or inadequate insurance coverage, limiting the availability of life-saving treatments for many patients.

Furthermore, despite technological breakthroughs, AAA treatments such as surgical repair and endovascular aneurysm repair (EVAR) are associated with risks such as endoleaks, graft migration, and renal failure. These potential side effects dissuade patients from undergoing surgery and pose a challenge for medical practitioners in managing long-term outcomes.

Category-wise Acumens

What Factors Contribute to the Increasing Demand for Endovascular Aneurysm Repair Surgery?

According to analyst, the endovascular aneurysm repair (EVAR) segment is expected to dominate the segment within the abdominal aortic aneurysm treatment market during the forecast period. EVAR is a less invasive choice than open surgery, resulting in faster recovery times, shorter hospital stays, and decreased immediate postoperative hazards. This appeal considerably boosts its popularity among both physicians and patients, making it especially ideal for elderly patients or those with significant comorbidities for whom traditional open surgery carries greater risks.

Continuous advances and breakthroughs in endovascular technologies, including better graft designs and improved imaging techniques, have increased EVAR’s efficacy and safety. These developments enable EVAR to be applied to a greater range of AAA anatomies and pathologies, increasing the treatment method’s commercial reach and acceptance.

Furthermore, a rising body of clinical evidence demonstrating the long-term efficacy and cost-effectiveness of EVAR versus open surgery has affected guidelines and recommendations. This data, combined with aggressive promotion by healthcare providers and advantageous reimbursement circumstances in many locations, has cemented EVAR’s place as the primary treatment choice in the AAA market.

How do the Hospitals propel the Abdominal Aortic Aneurysm Treatment Market?

The hospital segment is estimated to hold the largest share of the abdominal aortic aneurysm treatment market during the forecast period. Hospitals are better equipped with advanced medical technologies and equipment required for difficult treatments like AAA repairs. They have the infrastructure for both open operations and endovascular procedures, including specialist operating rooms and high-quality imaging systems, making them the best choice for such intense treatments.

Hospitals use a multidisciplinary team approach, which is critical for treating abdominal aortic aneurysms. These teams often include vascular surgeons, cardiologists, anesthesiologists, and radiologists, who work together to develop a complete treatment plan that addresses the intricacies and potential problems of AAA treatments. This integrated care strategy improves patient outcomes and helps hospitals maintain their market dominance.

Furthermore, patients trust hospitals more when they have serious diseases that require advanced interventions. Also, most referrals from primary care doctors and specialists are routed to hospitals because of their large resources and perceived dependability. This naturally directs a greater number of people seeking AAA care to hospitals, maintaining their market dominance.

Gain Access to Abdominal Aortic Aneurysm Treatment Market Report Methodology

Country/Region-wise Acumens

How will the Demand for AAA Treatment in North America Influence the Market?

North America region is estimated to dominate the abdominal aortic aneurysm treatment market during the forecast period. North America, particularly the United States, has some of the world’s most advanced healthcare facilities and medical technology businesses. This well-established healthcare infrastructure encourages the use of modern therapies and operations for abdominal aortic aneurysms, including novel minimally invasive approaches that improve patient outcomes.

The region is one of the world’s highest per capita healthcare expenses. This financial investment in health services ensures that people have access to high-quality care, including specialist therapies for illnesses like AAA. The region’s strong insurance systems and healthcare financing also help to make expensive and sophisticated treatments more affordable for patients.

Furthermore, North America has a large elderly population, which is a major risk factor for abdominal aortic aneurysms. In addition, lifestyle variables common in the region, such as high rates of smoking and obesity, contribute to the prevalence of AAA. These demographic and lifestyle characteristics fuel the demand for effective AAA treatment, supporting the region’s market leadership.

What Factor Contributes to the Growth of AAA Treatment in Europe?

Europe is estimated to exhibit substantial growth within the abdominal aortic aneurysm treatment market during the forecast period. Many European countries have launched screening programs for abdominal aortic aneurysms, with a focus on elderly males who are more at risk. These programs promote early detection, which increases the likelihood of successful treatment and results. This proactive approach to public health policy directly increases the demand for treatment services.

Furthermore, Europe has strong healthcare legislation and broad insurance coverage, including state-funded healthcare systems in many nations. These methods ensure that a larger segment of the population gets access to important medical treatments, including expensive procedures such as AAA. This accessibility promotes continued expansion in the treatment market.

Competitive Landscape

The abdominal aortic aneurysm (AAA) treatment market is characterized by continuous improvements in medical technology and the development of novel therapeutic methods. Regulatory licenses and clinical trials have a significant impact on competitive dynamics as companies attempt to achieve demanding healthcare requirements.

Some of the prominent players operating in the abdominal aortic aneurysm treatment market include

• Lombard Medical, Inc.
• L.Gore & Associates
• Endologix, Inc.
• Medtronic
• Cardinal
• Terumo Corporation
• Jotec Gmbh
• Cook Medical, Inc.
• Cvt Surgical Center

Latest Developments

• In September 2020, Terumo Aortic announced the launch of the Treo abdominal stent graft system in the United States. This system is designed to treat patients with abdominal aortic aneurysms (AAA), which is a weakening of the abdominal aorta, the main artery that carries blood from the heart to the rest of the body.
• In August 2019, Endologix signed an exclusive distributor agreement with Boston Scientific, for the China market. Boston Scientific Corporation will be an exclusive distributor of Endologix products in China. Through this agreement, the company plans to expand its presence in one of the largest and fastest-growing EVAR markets in the world.

Abdominal Aortic Aneurysm Treatment Market Report Scope

Abdominal Aortic Aneurysm Treatment Market by Category

Treatment

• Surgery
• Open Surgery
• Endovascular Aneurysm Repair
• Medication
• Antihypertensive
• Antilipidemics
• Others

End-User

• Hospitals
• Clinics

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors.• Provision of market value (USD Billion) data for each segment and sub-segment.• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market.• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region.• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled.• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions.• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis.• Provides insight into the market through Value Chain.• Market dynamics scenario, along with growth opportunities of the market in the years to come.• 6-month post-sales analyst support.

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.